XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income (loss) $ 7,060,039 $ (6,315,587)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Stock-based compensation 49,880 18,580
Depreciation and amortization 246,650 281,448
Loss on disposal of fixed assets 13,988
Interest added to convertible note payable 344,991
Interest expense for reduction in convertible note conversion price 3,488,851
Defined benefit plan obligation (24,713)
Amortization of debt discount and warrant modification 35,265 164,572
Gain on change in fair value of warrant liabilities (7,780,000)
Changes in operating assets and liabilities:    
Accounts receivable, net 314,989 675,975
Inventories, net (81,590) 278,062
Prepaid expenses and other assets 31,399 (181,493)
Accounts payable (1,165,997) (340,839)
Accrued expenses and other liabilities (49,358) 195,473
Contract liabilities 44,167 (337,401)
Other 185,000
Net cash used in operating activities (1,294,556) (1,553,093)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property and equipment (10,424) (22,398)
Capitalization of internal use software costs (20,683)
Net cash used in investing activities (10,424) (43,081)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from exercise of Series B warrants 170,833
Proceeds from the sale of Series F preferred stock 1,500,000 950,000
Repayments on COVID loans (100,930) (160,514)
Proceeds from the exercise of Series F warrants 497,701
Proceeds (repayments) on other short-term loans (135,000) 514,000
Issuance costs for sale of preferred stock (159,293)
Net cash provided by financing activities 1,434,903 1,641,894
Effects of foreign exchange rates on cash flows 40,740 (41,823)
Net change in cash 170,663 3,897
Cash at beginning of period 3,613,996 819,024
Cash at end of period 3,784,659 822,921
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Interest cash paid 35,265 164,572
Income taxes paid
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Conversion of Preferred Stock Series F to Common Stock 2,191 59
Accrued dividends on Series F Preferred Stock 67,651 61,235
Deemed dividend on Series F Preferred stock and warrant 1,056,332 5,249,704
Accrued expense settled with Series B Warrant exercise $ 350,000